These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2786454)
1. Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines. Onozaki K; Akiyama Y; Okano A; Hirano T; Kishimoto T; Hashimoto T; Yoshizawa K; Taniyama T Cancer Res; 1989 Jul; 49(13):3602-7. PubMed ID: 2786454 [TBL] [Abstract][Full Text] [Related]
2. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1. Onozaki K; Tamatani T; Hashimoto T; Matsushima K Cancer Res; 1987 May; 47(9):2397-402. PubMed ID: 3494508 [TBL] [Abstract][Full Text] [Related]
4. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines. Kamijo R; Takeda K; Nagumo M; Konno K J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994 [TBL] [Abstract][Full Text] [Related]
5. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes. Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499 [TBL] [Abstract][Full Text] [Related]
6. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines. Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS). Leung KN; Mak NK; Fung MC; Hapel AJ Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222 [TBL] [Abstract][Full Text] [Related]
8. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. Chiu CP; Lee F J Immunol; 1989 Mar; 142(6):1909-15. PubMed ID: 2784140 [TBL] [Abstract][Full Text] [Related]
9. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Zhang L; Nakaya K; Yoshida T; Kuroiwa Y Cancer Res; 1992 Sep; 52(17):4634-41. PubMed ID: 1324788 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative. Melamed D; Resnitzky D; Haimov I; Levy N; Pfarr CM; Yaniv M; Kimchi A Cell Growth Differ; 1993 Aug; 4(8):689-97. PubMed ID: 8398910 [TBL] [Abstract][Full Text] [Related]
11. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines. Dawson MJ; Trapani JA J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752 [TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. Feng R; Shen S; Hui H; Jin M Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416 [TBL] [Abstract][Full Text] [Related]
13. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells. Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748 [TBL] [Abstract][Full Text] [Related]
14. Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937. Taimi M; Defacque H; Commes T; Favero J; Caron E; Marti J; Dornand J Immunology; 1993 Jun; 79(2):229-35. PubMed ID: 8344702 [TBL] [Abstract][Full Text] [Related]
15. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868 [TBL] [Abstract][Full Text] [Related]
16. Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects. Borsellino N; Crescimanno M; Flandina C; Flugy A; D'Alessandro N Anticancer Res; 1994; 14(6B):2643-8. PubMed ID: 7872695 [TBL] [Abstract][Full Text] [Related]
17. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation. Koyama N; Harada N; Takahashi T; Mita S; Okamura H; Tominaga A; Takatsu K Immunology; 1988 Feb; 63(2):277-83. PubMed ID: 3280472 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the expression of IL-6 in human monocytes. Navarro S; Debili N; Bernaudin JF; Vainchenker W; Doly J J Immunol; 1989 Jun; 142(12):4339-45. PubMed ID: 2786029 [TBL] [Abstract][Full Text] [Related]
19. Costimulatory signals are required for optimal proliferation of human natural killer cells. Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of early and late markers of murine myeloid differentiation by interferon-gamma and interleukin-6. Ruhl S; Pluznik DH J Cell Physiol; 1993 Apr; 155(1):130-8. PubMed ID: 8468358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]